Low-dose HRT patches carry 26% less risk than oral therapy
Hormone replacement therapy (HRT) skin patches containing low doses of estrogen carry less risk of stroke than oral therapy and may represent a safer alternative.read more
View ArticleFirst warfarin replacement approved
Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA approval for the prevention of stroke and blood clots in patients with atrial fibrillation. It is the first replacement for...
View ArticleMultifaceted strategies can improve patients' medication adherence
Interventions for medication adherence should be multifaceted, speakers told attendees at the recent Pharmacy and Technology Conference in San Diego sponsored by the National Association of Chain Drug...
View ArticleFormer finasteride users who have sexual side effects at increased risk for...
Men who developed sexual side effects from finasteride have been shown to suffer from depressive symptoms and suicidal thoughts, said a recent study.read more
View ArticleStatin use may be linked to increase in cataract risk
A recent study indicates that patients taking statins are at a higher risk of developing cataracts at an earlier age than those not taking them.read more
View ArticleReadmission rates drop with better med reconciliation and therapy management
When pharmacist care managers bird-dog patients pre- and post-discharge, readmission rates drop.read more
View ArticleGet ready for more patients with full implementation of Affordable Care Act
With President Obama’s re-election, implementation of the Affordable Care Act (ACA) will move forward, full speed ahead, according to one industry expert.read more
View ArticleAnalgesic use linked to hearing loss in women
Women who regularly took the analgesics ibuprofen or acetaminophen 2 or more days per week had an increased risk of hearing loss, according to a study.read more
View ArticleLow-dose HRT patches carry 26% less risk than oral therapy
Hormone replacement therapy (HRT) skin patches containing low doses of estrogen carry less risk of stroke than oral therapy and may represent a safer alternative.
View ArticleFirst warfarin replacement approved
Dabigatran etexilate (Pradaxa, Boehringer Ingelheim) has received FDA approval for the prevention of stroke and blood clots in patients with atrial fibrillation. It is the first replacement for...
View ArticleMultifaceted strategies can improve patients' medication adherence
Interventions for medication adherence should be multifaceted, speakers told attendees at the recent Pharmacy and Technology Conference in San Diego sponsored by the National Association of Chain Drug...
View Article
